|
Volumn 90, Issue , 2004, Pages 279-301
|
Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 ((2 CHLOROETHYL)(2 MESYLOXYETHYL)AMINO)BENZOYLGLUTAMIC ACID;
4-((2-CHLOROETHYL)(2-MESYLOXYETHYL)AMINO)BENZOYLGLUTAMIC ACID;
5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE;
5-(1-AZIRIDINYL)-2,4-DINITROBENZAMIDE;
ANTINEOPLASTIC AGENT;
AZIRIDINE DERIVATIVE;
CHLORMETHINE DERIVATIVE;
GAMMA GLUTAMYL HYDROLASE;
GLUTAMIC ACID DERIVATIVE;
NITROREDUCTASE;
PRODRUG;
ARTICLE;
BYSTANDER EFFECT;
CELL CULTURE;
CELL FRACTIONATION;
CELL SURVIVAL;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
GENE THERAPY;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
METABOLISM;
METHODOLOGY;
OVARY TUMOR;
SUICIDE TRANSGENE;
ANTINEOPLASTIC AGENTS;
AZIRIDINES;
BYSTANDER EFFECT;
CELL SURVIVAL;
FEMALE;
GAMMA-GLUTAMYL HYDROLASE;
GENE THERAPY;
GENES, TRANSGENIC, SUICIDE;
GLUTAMATES;
HUMANS;
NITROGEN MUSTARD COMPOUNDS;
NITROREDUCTASES;
OVARIAN NEOPLASMS;
PRODRUGS;
SUBCELLULAR FRACTIONS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
EID: 1542467512
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|